drugset / Trial / NCT00028639
PS-341 in Treating Women With Metastatic Breast Cancer
Treatment
Summary
RATIONALE: PS-341 may stop the growth of tumor cells by blocking the enzymes necessary for cancer cell growth. PURPOSE: Phase II trial to study the effectiveness of PS-341 in treating women who have metastatic breast cancer.
Timeline
- Start
- 2001-08
- Primary completion
- 2003-11
- Completion
- 2003-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bortezomib | Small molecule | — | Intravenous |